NTRC 0652-0

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameNTRC 0652-0
Drug Alias NameNTRC 0652-0NTRC-0652-0
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase LCK inhibitors
TargetsTyrosine-protein kinase LCK
Therapy Area/IndicationsCytokine Release SyndromeCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNTRC Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesNTRC Therapeutics BV
Inactive CompaniesN/A
Active IndicationsCytokine Release SyndromeCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A